NCT05458219 2025-11-10
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Recruiting
Clinical Trials
1 trialsLocally Advanced Unresectable or Metastatic Solid Tumors × folfirinox × Other solid neoplasm × Clear all